Manipal Health Enterprises is set to announce the allotment of its IPO shares today. Investors can verify their allotment status through KFin Technologies, BSE, or NSE websites. The company's shares are expected to debut on the stock market on August 5, with a grey market premium indicating a cautious start.
The IPO, open from July 29 to July 31, was subscribed 4.92 times overall. Institutional demand was strong, with the Qualified Institutional Buyers (QIB) portion subscribed 8.25 times. The Non-Institutional Investor (NII) category saw a 1.02 times subscription, while the Retail Individual Investor (RII) segment received bids for 93% of the shares reserved for them.
The public issue comprised a fresh issue of 13.56 crore equity shares worth Rs 8,000 crore and an Offer for Sale (OFS) of 2.16 crore shares valued at Rs 1,275.22 crore, totaling Rs 9,275.22 crore. The price band was set at Rs 560–590 per share. Kotak Mahindra Capital was the book-running lead manager, and KFin Technologies served as the registrar.
Investors can check their allotment status through KFin Technologies by visiting their IPO allotment page, selecting Manipal Health Enterprises, and entering their PAN, application number, or DP/Client ID. Alternatively, they can use the NSE or BSE websites to verify their status.
Manipal Health Enterprises, founded in 2010, is one of India's largest healthcare providers, operating 49 hospitals with 13,037 licensed beds and 21 clinics across India as of March 31, 2026. The company plans to use Rs 5,378 crore from the IPO proceeds to repay debt and Rs 574 crore to acquire a minority stake in Sahyadri Hospitals.
Background
Manipal Health Enterprises has grown significantly since its founding in 2010, becoming a major player in India's healthcare sector. The IPO proceeds are strategically aimed at reducing debt and expanding their healthcare services, reflecting the company's commitment to strengthening its market position.
As the IPO allotment concludes, investors will be keenly watching the stock's market debut on August 5. The company's strategic use of IPO proceeds to strengthen its financial position and expand its healthcare offerings will be critical to its future growth trajectory.
